Biosimulation Market to Register Substantial Expansion in Coming Years

The biosimulation market is expected to reach USD 2.88 Billion by 2022 from USD 1.20 Billion in 2016 growing at a CAGR of 15.9%

(firmenpresse) - The biosimulation market is expected to reach USD 2.88 billion by 2022 from USD 1.38 billion in 2017, growing at a CAGR of 15.9%. Factors such as the increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets are driving the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=838

Based on product & service, the market is segmented into software and services. The biosimulation services segment is expected register the highest CAGR during the forecast period. The high growth in this segment is attributed to the recurring need for services such as data analysis and consulting services.

Based on applications, the biosimulation market is segmented into drug discovery, drug development, and other applications (nutraceuticals and agri-food production). The other applications segment is expected to register the highest CAGR during the forecast period. The increasing use of biosimulation software and techniques by the defense, industrial bioprocessing, nutraceuticals, and agri-food production industries will drive the growth of this market segment in the coming years.

Based on delivery model, the biosimulation market is segmented into ownership models and subscription models. The ownership models segment is expected to register the highest CAGR during the forecast period. Buyers mainly opt for these delivery models due to the security benefits associated with them are the major factors that are expected to drive the growth of the ownership models segment.

Based on the end user, the biosimulation market is segmented into research institutes, pharmaceutical and biotechnology companies, contract research organizations (CROs), regulatory authorities, and other end users (consulting firms, defense research and development organizations, nutraceutical companies, and food and agricultural companies). The pharmaceutical and biotechnology companies are expected to dominate the market during the forecast period. The growth of this segment is mainly attributed to factors such as the increased R&D budgets of pharmaceutical and biotechnology companies and increasing adoption of inorganic growth strategies by different biosimulation service providers.



Among the four regional segments covered in the biosimulation market—North America, Europe, Asia, and the Rest of the World (RoW), Europe is expected to grow at the highest CAGR during the forecast period. The growing focus on research-related funding activities by governments is expected to assist in the development of drug discovery and development process, thus driving the demand for biosimulation in the European region.

Read more: https://www.prnewswire.com/news-releases/biosimulation-market-worth-288-billion-usd-by-2022-667859333.html
Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: dheerajshaha67
Datum: 14.08.2019 - 12:53 Uhr
Sprache: Deutsch
News-ID 1744855
Anzahl Zeichen: 3235

Kontakt-Informationen:
Ansprechpartner: Dheeraj Shaha
Stadt:

Northbrook

Telefon: 18886006441

Kategorie:

Biotechnologie

Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 14.08.2019

Diese Pressemitteilung wurde bisher 502 mal aufgerufen.

Microplate Systems Market | Increasing R&D Expenditure in the Pharmaceutical Industry ...
The growth of this market is mainly driven by factors such as the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, technological advancements, and growing prevalence of diseases. The report "Microplate Systems Market by Product (Microplate R

3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years ...
A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private

Immuno Oncology Assays : Research Application Transforming the Industrial Business ...
What the Immuno Oncology Assays Market looks like? Growth in Immuno Oncology Assays Market is largely driven by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. According to the new market research report "Immuno Onco

Weitere Mitteilungen von MnM

Conagen erweitert sein Gamma-Decalacton-Portfolio (y-Decalacton) auf 20 GMO-freie Lactone ...
Conagen, ein Biotechnologie-Unternehmen mit Sitz in Boston, das sich auf Forschung und Entwicklung konzentriert, gab heute seine mit firmeneigener Technologie erarbeitete bahnbrechende Entwicklung in der kommerziellen Produktion von natürlichen aromatischen ?-Decalacton-Verbindungen aus natürl

Glycomine, Inc. gibt Serie-B-Finanzierungüber 33 Millionen Dollar zur Weiterentwicklung seiner Therapie für angeborene Erkrankungen der Glykosylierung (Congenital Disease of Glycosylation) bekannt ...
Glycomine, Inc., ein Biotechnologieunternehmen, das auf die Entwicklung innovativer Therapien für seltene Erkrankungen spezialisiert ist, meldete heute, 33 Millionen Dollar im Rahmen einer Finanzierungsrunde (Serie B) unter der Führung von Novo Holdings A/S beschafft zu haben. Mit dem Finanzi

Cell Sorting Market Comprehensive Insights and Growth Potential In The Future ...
According to a new market research report "Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) - Forecasts to 20

3D Cell Culture Market Emerging Trends and Upcoming Growth ...
According to a new market research report "3D Cell Culture Market by Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) - Global Forecast to 2022", pu